Review ArticleREVIEWS AND CONTEMPORARY UPDATES
Open Access
Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia
Mila Pastrak, Alaa Abd-Elsayed, Frederick Ma, Bruce Vrooman and Ognjen Visnjevac
Ochsner Journal December 2021, 21 (4) 387-394; DOI: https://doi.org/10.31486/toj.21.0038
Mila Pastrak
1Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
BScAlaa Abd-Elsayed
2Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI
MD, MPH, FASAFrederick Ma
3Bloor Pain Specialists, Toronto, Ontario, Canada
MDBruce Vrooman
4Department of Anesthesiology and Pain Management, Dartmouth-Hitchcock Medical Center, Lebanon, NH
MDOgnjen Visnjevac
1Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
3Bloor Pain Specialists, Toronto, Ontario, Canada
5Department of Anesthesiology and Pain Management Cleveland Clinic Canada, Toronto, Ontario, Canada
MD, FRCPC, DABAREFERENCES
- 1.↵
- Jones GT,
- Atzeni F,
- Beasley M,
- Flüß E,
- Sarzi-Puttini P,
- Macfarlane GJ
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Woolf CJ
- 6.↵
- Staud R,
- Vierck CJ,
- Robinson ME,
- Price DD
- 7.↵
- 8.↵
- 9.↵
- Cook DB,
- Lange G,
- Ciccone DS,
- Liu WC,
- Steffener J,
- Natelson BH
- 10.↵
- Gracely RH,
- Petzke F,
- Wolf JM,
- Clauw DJ
- 11.
- Jensen KB,
- Kosek E,
- Petzke F,
- et al.
- 12.
- 13.↵
- Diers M,
- Schley MT,
- Rance M,
- et al.
- 14.↵
- Cifre I,
- Sitges C,
- Fraiman D,
- et al.
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- Larson AA,
- Giovengo SL,
- Russell JI,
- Michalek JE
- 20.↵
- Arnold LM,
- Fan J,
- Russell IJ,
- et al.
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- Iacobucci GJ,
- Visnjevac O,
- Pourafkari L,
- Nader ND
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- Dale O,
- Somogyi AA,
- Li Y,
- Sullivan T,
- Shavit Y
- 30.↵
- Phillips K,
- Clauw DJ
- 31.↵
- Murrough JW,
- Iosifescu DV,
- Chang LC,
- et al.
- 32.↵
- 33.↵FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic. U.S. Food and Drug Administration. March 5, 2019. Accessed November 24, 2021. www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified
- 34.↵
- Sörensen J,
- Bengtsson A,
- Bäckman E,
- Henriksson KG,
- Bengtsson M
- 35.↵
- Sörensen J,
- Bengtsson A,
- Ahlner J,
- Henriksson KG,
- Ekselius L,
- Bengtsson M
- 36.↵
- Graven-Nielsen T,
- Kendall SA,
- Henriksson KG,
- et al.
- 37.↵
- Noppers I,
- Niesters M,
- Swartjes M,
- et al.
- 38.↵
- Cohen SP,
- Verdolin MH,
- Chang AS,
- Kurihara C,
- Morlando BJ,
- Mao J
- 39.↵
- Hanna AF,
- Smith AJ
- 40.↵
- 41.↵
- Cohen SP,
- Bhatia A,
- Buvanendran A,
- et al.
- 42.↵
- 43.↵
- Kishimoto T,
- Chawla JM,
- Hagi K,
- et al.
- 44.↵
- 45.↵
- Liu RJ,
- Lee FS,
- Li XY,
- Bambico F,
- Duman RS,
- Aghajanian GK
- 46.↵
In this issue
Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia
Mila Pastrak, Alaa Abd-Elsayed, Frederick Ma, Bruce Vrooman, Ognjen Visnjevac
Ochsner Journal Dec 2021, 21 (4) 387-394; DOI: 10.31486/toj.21.0038